Patents by Inventor Eli Mordechai

Eli Mordechai has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160266874
    Abstract: A method includes receiving, by a computer, input from a client device. The input is indicative of a software environment for software to be developed by a user. The method further includes analyzing, by the computer, the received input against a knowledge base to generate a technology recommendation for the user to use to develop the software. The method also includes providing, by the computer, the technology recommendation to the client device.
    Type: Application
    Filed: October 30, 2013
    Publication date: September 15, 2016
    Inventors: Tomer Priel, Karen Cohen, Eli Mordechai
  • Patent number: 9411803
    Abstract: Disclosed herein are a system, non-transitory computer-readable medium, and method for responding to natural language queries. Keywords likely to appear in a natural language query are determined and each likely keyword is associated with a module. A response to a natural language query comprises information generated by each module associated with a likely keyword appearing in the natural language query.
    Type: Grant
    Filed: September 28, 2012
    Date of Patent: August 9, 2016
    Assignee: Hewlett Packard Enterprise Development LP
    Inventors: Ohad Assulin, Ira Cohen, Eli Mordechai, Boaz Shor, Alon Sade
  • Publication number: 20160117680
    Abstract: Payment processing as disclosed includes maintaining registration data and masked payment data so that it is accessible to a computing device. The registration data represents a registration of the computing device with a remote payment processing system. The masked payment data indirectly, but not directly, identifies payment data associated with a user. An application programming interface for receiving a payment request from a merchant application is exposed. In response to receiving the payment request for an amount via the interface, the user is prompted for authorization data. Only upon verification of the authorization data, the registration data, the masked payment data, and the amount are communicated to the payment processing system.
    Type: Application
    Filed: June 27, 2013
    Publication date: April 28, 2016
    Inventors: Tomer Priel, Adi Kidron, Eli Mordechai
  • Patent number: 9297048
    Abstract: The present invention relates to an antibiotic resistance profile for Neisseria gonorrhoeae by assessing the presence of mutations (e.g., SNP) in antibiotic resistant genes that confer bacterial resistance against antibiotics such as penicillin, tetracycline, fluoroquinolones, cephalosporin, macrolides and spectinomycin. There is provided a method and a kit for generating an antibiotic resistance profile for Neisseria gonorrhoeae by utilizing a multiplex PCR to amplify segments of antibiotic-resistant genes, allele-specific primer extension to detect gene mutation, and detection of such gene mutations with gel electrophoresis, capillary electrophoresis, or DNA microarray. The present method provides useful information to physicians relating the antibiotic susceptibility of Neisseria gonorrhoeae against different classes of antibiotics.
    Type: Grant
    Filed: June 2, 2011
    Date of Patent: March 29, 2016
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Sergey Balashov, Eli Mordechai, Martin E. Adelson, Scott E. Gygax
  • Publication number: 20160085664
    Abstract: Examples disclosed herein relate to generating a fingerprint representing a response of an application to a simulation of a fault of an external service. Examples include causing simulation of a fault of an external service in a simulation of the external service, and generating a testing application fingerprint representing a response of an application to the simulation of the fault of the external service during the testing of the application.
    Type: Application
    Filed: June 20, 2013
    Publication date: March 24, 2016
    Inventors: Yair Horovitz, Ira Cohen, Eli Mordechai
  • Publication number: 20160070678
    Abstract: Managing a presentation includes identifying audience member interactions with a plurality of presentation pages. Each of the plurality of presentation pages is associated with data indicative of the audience member interactions. That data is processed to identify an action plan specifying an update to the presentation. That update is based on identified audience member interactions with at least one of the plurality of presentation pages. The action plan is implemented to update the presentation.
    Type: Application
    Filed: August 28, 2013
    Publication date: March 10, 2016
    Inventors: Adi Kidron, Adam Lahav, Eli Mordechai, Amit Erental
  • Patent number: 9267179
    Abstract: Methods and compositions useful in the detection and identification of species of Candida are disclosed. The compositions are combinations of oligonucleotides, where the forward primers of the primer pairs have identical sequences, while each reverse primer of the primer pairs has a unique sequence relative to all of the other reverse primers; or the reverse primers of the primer pairs have identical sequences, while each forward primer of the primer pairs has a unique sequence relative to all of the other forward primers. The oligonucleotides also include probes capable of detecting these amplicons, and sequencing primers for determining, in primer extension reactions, the nucleotide sequences contained within the amplicons. The detection of an amplicon indicated that the sample contains at least one isolate of Candida ablicans, Candida glabrata, Candida parapsilosis, or Candida tropicalis, and the nucleotide sequence data is used to determine which of these four Candida species is present.
    Type: Grant
    Filed: July 5, 2013
    Date of Patent: February 23, 2016
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Jason Trama, Martin E. Adelson, Eli Mordechai
  • Publication number: 20160034380
    Abstract: A monitor that monitors an application is provided herein. The monitor provides a monitor function that monitors an application. The monitor embeds the monitor function in meta data of a code base of the application. The monitor function embedded in the code base is activated. The monitor function is used to monitor data associated therewith during deployment of the application.
    Type: Application
    Filed: September 21, 2012
    Publication date: February 4, 2016
    Applicant: Hewett-Packard Development Company, L.P.
    Inventors: Inbar Shani, Amichai NITSAN, Eli MORDECHAI
  • Publication number: 20150370618
    Abstract: Recording an unstructured event in context can include detecting a first occurrence indicative of a start to the unstructured event utilizing a sensing feature of a client device. Upon detection of the first occurrence, device activity data associated with the client device is tracked. A second occurrence indicative an end to the unstructured event is detected utilizing the sensing feature. Following detection of the second occurrence, an event object for the unstructured event spanning between the first and second events is presented. The event object includes or is otherwise associated with the device activity data tracked during the timespan.
    Type: Application
    Filed: April 29, 2013
    Publication date: December 24, 2015
    Inventors: Erez Yaary, Eli Mordechai, Kobi Eisenberg, Adi Kidron
  • Patent number: 9145593
    Abstract: Methods for using oligonucleotides in the detection of Aspergillus fumigatus are disclosed. The oligonucleotides of the invention have nucleotide sequences derived from the gene encoding the cytochrome P450 14 alpha-sterol demethylase (the cyp51A protein) of Aspergillus fumigatus. The oligonucleotides include primers capable of producing amplicons specific to cyp51A in polymerase chain reactions using nucleic acids isolated from Aspergillus fumigatus as templates. The oligonucleotides also include probes capable of detecting these cyp51A-specific amplicons. The oligonucleotides of the invention also include primers for nucleotide sequencing reactions to determine whether an isolate of Aspergillus fumigatus is more tolerant than wild-type Aspergillus fumigatus to a triazole.
    Type: Grant
    Filed: September 17, 2012
    Date of Patent: September 29, 2015
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Jason Trama, Martin E Adelson, Eli Mordechai
  • Patent number: 9002830
    Abstract: A method of determining reliability of electronic documents associated with an event occurring in connection with a computing device may comprise, with a processor, composing a number of search queries based on text included in an event message, searching for a number of electronic documents via a network, said searching performed based on the composed search queries, and ranking the electronic documents identified by said searching based upon an indication of reliability in addressing the event associated with the event message, in which, ranking the electronic documents comprises applying a content source ranking criteria.
    Type: Grant
    Filed: July 12, 2010
    Date of Patent: April 7, 2015
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Ira Cohen, Gilad Barash, Eli Mordechai, Carl Staelin
  • Patent number: 8956814
    Abstract: Disclosed are methods and compositions for conducting assays utilizing real-time polymerase chain reactions (“PCRs”) in detection of serotypes L I, L II, and L III, but not stereotype B, of Chlamydia trachomatis, capable of causing lymphogranuloma venereum (“LGV”). These assays take advantage of a deletion occurring in the cytotoxin gene locus specific to the L I, L II, and L III serotypes. Each assay employs a first primer having a nucleotide sequence flanking one side of the deletion point and a second primer having a nucleotide sequence flanking the other side of the deletion point, wherein the first primer and the second primer are capable of hybridizing respectively to the plus strand and the minus strand of the genome of Chlamydia trachomatis during PCR. Synthesis during PCR of a sequence-specific amplicon containing this deletion point indicates that the sample contains nucleic acid specific to an LGV-causing serotype of Chlamydia trachomatis.
    Type: Grant
    Filed: October 23, 2012
    Date of Patent: February 17, 2015
    Assignee: Medical Diagnostics Laboratories, LLC
    Inventors: Jason Trama, Eli Mordechai, Martin E. Adelson
  • Patent number: 8932832
    Abstract: Methods are described herein for detecting and identifying distinct species of nucleic acids, in a single container, for example, from a certain genus of infectious agents or otherwise causative agents comprising, for example, providing a forward PCR primer common to a homologous gene region between the distinct species, and providing a reverse PCR primer common to a homologous gene region between the distinct species, to thereby define a PCR target region amongst the species, and providing a first oligonucleotide probe specific to a nucleic acid sequence within the target region that is characteristic of a first species, providing a second oligonucleotide probe specific to a nucleic acid sequence within the target region that is characteristic of a second species, wherein the first and second oligonucleotide probes are each detectably labeled with distinctly different detectable labels, conducting a PCR reaction in the container by means of the primers to amplify the target region amongst the species, and de
    Type: Grant
    Filed: August 26, 2011
    Date of Patent: January 13, 2015
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: Martin E. Adelson, Melanie Feola, Jason Trama, Eli Mordechai
  • Publication number: 20140377749
    Abstract: The present invention is directed to the discovery of single nucleotide polymorphisms (SNPs) in the presence of metronidazole-resistant Trichomonas vaginalis. The presence of G76C, C213G, or C318A (SNP) in tvntr 4 or the presence of A238T, G427C, or T476C (SNP) in tvntr6 provides a reliable biomarker for the presence of metronidazole-resistant Trichomonas vaginalis. The present invention further provides reagents used for detecting the SNPs to screen subjects for metronidazole resistance in Trichomonas vaginalis.
    Type: Application
    Filed: April 22, 2014
    Publication date: December 25, 2014
    Applicant: MEDICAL DIAGNOSTIC LABORATORIES, LLC
    Inventors: David W. Hilbert, Scott E. Gygax, Martin E. Adelson, Eli Mordechai, Jessica Schuyler, Teresa Paulish-Miller
  • Publication number: 20140372347
    Abstract: Methods performed by a physical computing system include automatically identifying, using at least one trained classifier, an action for responding to an anomaly in the execution of the application in a cloud computing system. The at least one trained classifier relates a metrics set to a result of performing an action for addressing an anomaly. Systems and computer readable media are also described herein.
    Type: Application
    Filed: October 10, 2011
    Publication date: December 18, 2014
    Inventors: Ira Cohen, Ahad Assulin, Eli Mordechai, Refael Dakar
  • Patent number: 8859722
    Abstract: Disclosed is the cloning, expression and purification of a hemolysin protein and its protein fragments in Anaplasma phagocytophilum. The recombinant hemolysin and its protein fragments are useful in the ELISA detection of anaplasma pathogen. The use of same as a kit for ELISA is also disclosed.
    Type: Grant
    Filed: July 30, 2012
    Date of Patent: October 14, 2014
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: John G. Hoey, Denise P. Dimitrov, Lisa P. Huang, Martin E. Adelson, Eli Mordechai
  • Publication number: 20140303072
    Abstract: Disclosed are diagnostic methods for determining a subtype of methicillin-resistant Staphylococcus aureus (MRSA) in a biological sample of a mammal. Methods include providing a biological sample of the mammal, performing a PCR analysis of the biological sample, and analyzing the PCR amplicons with respect to their sizes so as to determine for type I, type II, type III, type IV or type V MRSA that may be present in the biological sample. Further example embodiments include using at least one mecA primer pair and/or using at least one Staphylococcus aureus nuc primer pair in the PCR analysis. Further disclosed are methods for screening populations for MRSA, and methods of treating a mammal testing positive for Type IV MRSA. Also disclosed are kits for determining a MRSA subtype in a mammal and isolated primers that may be used in the present methods and kits.
    Type: Application
    Filed: March 18, 2014
    Publication date: October 9, 2014
    Applicant: MEDICAL DIAGNOSTIC LABORATORIES, LLC
    Inventors: Scott Elliot Gygax, Christina Lim Overmyer, Lisa A. DeSalvia, Martin Adelson, Eli Mordechai
  • Patent number: 8763005
    Abstract: Embodiments of the present invention are directed to application-service provision by application-service-provider centers to remote application-service consumers, including small businesses, medium-sized businesses, and other similarly-sized institutions and organizations, as well as to users of individual computers, such as home computers. Rather than executing applications at an application-service-provider center, the applications are instead distributed to remote client sites for execution by virtual machines controlled and managed by an application-service-provider center. Execution of the applications by virtual machines at remote client sites alleviates constraints and bottlenecks associated with communications between client computers and remotely executing applications, while providing management capabilities and security that allow the application-service center to manage application execution as if the remotely executing applications were executing within the application-service center.
    Type: Grant
    Filed: July 24, 2009
    Date of Patent: June 24, 2014
    Assignee: Hewlett-Packard Development Company, L.P.
    Inventors: Carl Staelin, Mani Fischer, Oren Ariel, Eli Mordechai, Chen Finkelstein, Nimrod Rod
  • Patent number: 8741563
    Abstract: The present invention is directed to the discovery of single nucleotide polymorphisms (SNPs) in the presence of metronidazole-resistant Trichomonas vaginalis. The presence of G76C, C213G, or C318A (SNP) in tvntr 4 or the presence of A238T, G427C, or T476C (SNP) in tvntr6 provides a reliable biomarker for the presence of metronidazole-resistant Trichomonas vaginalis. The present invention further provides reagents used for detecting the SNPs to screen subjects for metronidazole resistance in Trichomonas vaginalis.
    Type: Grant
    Filed: November 19, 2012
    Date of Patent: June 3, 2014
    Assignee: Medical Diagnostic Laboratories, LLC
    Inventors: David W. Hilbert, Scott E. Gygax, Martin E. Adelson, Eli Mordechai, Jessica Schuyler, Teresa Paulish-Miller
  • Publication number: 20140141457
    Abstract: Disclosed are the cloning and expression of a novel antigen of Bartonella henselae. The recombinant polypeptide is found to be highly immunogenic and is useful as a diagnostic test antigen. The polypeptide of the present invention provides the basis of a diagnostic assay that is sensitive, rapid and accurate diagnosis of infection with Bartonella henselae using patient's sera. Disclosed also are the ELISA for both IgG and IgM and allows diagnosis of early and late infection.
    Type: Application
    Filed: October 8, 2013
    Publication date: May 22, 2014
    Applicant: MEDICAL DIAGNOSTIC LABORATORIES, LLC
    Inventors: John G. Hoey, Lisa P. Huang, Martin E. Adelson, Eli Mordechai